The Best Quarter of the Recovery, Sold as News: Maintaining Spectrum Brands at Outperform

Results vs. Consensus

Quality of Beat

• Revenue: The highest-quality top line of the arc, with one honest asterisk. Reported +4.9% benefited from $22.9M of FX, so organic was a more modest +1.5%, and roughly $9M of GPC sales were pull-forward (a ~$6M pre-buy ahead of the EMEA S/4HANA go-live plus ~$3M of e-commerce timing). Strip those and underlying organic growth is closer to flat-to-slightly-positive. But the signal is unambiguous: both flagship segments grew double-digits and gained share in flat-to-down categories.
• Margins: The cleanest improvement in the report. Gross margin expanded 60bps to 38.1% on pricing, cost actions, and FX, the first expansion of the recovery, and adjusted EBITDA grew 17.8% with H&G margin up 300bps and GPC margin up 40bps. After three quarters of margin compression, the operating leverage is finally turning the right way.
• EPS: For the first time in the arc, the adjusted EPS beat is operational. The $1.25 (vs. ~$1.07) was driven by the higher adjusted EBITDA and a smaller share count, not a one-time tax benefit. GAAP net income and EPS also rose on the $24M operating-income increase. This is the quarter where the EPS line finally reflects the business rather than below-the-line help.

Segment Performance

Global Pet Care

The growth engine accelerated. Reported sales rose 11.2% (organic +7.6%, up from +5.8% in Q1), with companion animal up low-double-digits and aquatics up mid-single-digits. North America grew mid-single-digits with Good 'n' Fun, DreamBone, Nature's Miracle, and FURminator all posting positive POS in flat-to-down categories, and EMEA grew high-single-digits on Good Boy's continued share gains and Tetra (celebrating its 75th year) outperforming a declining aquatics market. Roughly $9M was pull-forward (S/4 EMEA pre-buy plus e-commerce timing). Crucially, margin is now expanding too: adjusted EBITDA rose $6.8M to $56.8M at a 19.0% margin (up from 18.6%), so the segment is delivering growth and operating leverage simultaneously.

"Good 'n' Fun, DreamBone, Nature's Miracle and FURminator all posted positive POS for the quarter in categories that were flat or slightly down versus the prior year." — Faisal Qadir, CFO

Management is layering a price-pack-architecture initiative on top of the innovation engine, aiming to bring good-better-best clarity to a "messy and opaque" shelf, which it argues will lift the whole category. Marketing and advertising will step up sequentially in H2, peaking in Q3, to support the innovation slate.

Assessment: This is now a genuine growth segment, not a stabilizing one. Two consecutive accelerating quarters of organic growth, driven by share gains rather than category lift, with margin expanding, is exactly the inflection the thesis required. The pull-forward and FX flatter the headline, but the underlying share-gain trajectory is the highest-conviction part of the entire story.

Home & Garden

The high-margin franchise delivered its season opener in style: net sales up 11.3% on double-digit Controls growth and the warmest March on record, with retailers carrying appropriate inventory and reorder patterns supporting incremental sell-through. Share gains came across Spectracide, Hot Shot, Cutter, and Repel, and a new Spectracide liquid-fertilizer platform (named 2026 Product of the Year in lawn fertilizer) extended the innovation runway. Adjusted EBITDA jumped to $34.8M (from $26.7M) at a 20.5% margin, up a striking 300bps.

"Favorable weather trends highlighted by the warmest March on record in the U.S. led to a strong start to the season… our brands continue to win versus competition in the market with share gains in Spectracide, Hot Shot, Cutter and Repel." — Faisal Qadir, CFO

Management was careful to temper the strong start: most of the season (May–June) is still ahead, weather is inherently uncertain, and the full-year H&G plan assumes a normal season rather than an extrapolation of a hot March. April was described as "off to a great start."

Assessment: H&G is the cleanest growth-and-margin story in the portfolio and, per management, the year's fastest grower. The +300bps margin expansion is the standout, showing the value-brand portfolio's operating leverage when volume returns. The prudent move is to hold management to its normal-weather plan rather than capitalize the hot start, but the setup (lower retailer inventories, share gains, normal-weather upside) is favorable.

Home & Personal Care

HPC did its job: net sales fell 5.5% (organic -10.7%), but adjusted EBITDA still rose to $8.1M (from $7.3M) at a 3.4% margin (up from 2.9%), as pricing, cost actions, and SKU rationalization more than offset volume declines. North America fell mid-teens on appliance softness and tariff-driven price increases; EMEA fell mid-teens, weighed by one retailer's elevated inventory (now believed normalized); LatAm grew mid-single-digits. The direct-to-consumer pivot grew more than 200% year-over-year off a small base. The bigger news is structural: the Oaktree partnership creates a dedicated, well-capitalized standalone vehicle for HPC.

"Our focus remains on improving profitability with plans in place to deliver full-year adjusted EBITDA growth versus prior year despite a projected decline in net sales." — Faisal Qadir, CFO

Assessment: HPC is now the textbook "manage for profit, monetize the option" segment. Growing EBITDA on declining sales is the right outcome while the durables consumer remains weak, and the Oaktree structure converts a stuck asset into a financed, separable platform. The segment remains a top-line drag, but a shrinking, profit-improving, and now strategically de-risked one.

Key Topics & Management Commentary

Overall Management Tone: Confident on execution, deliberately cautious on the macro. Management led with the milestone (return to growth, raised EBITDA guide, the Oaktree deal) but repeatedly tempered it, declining to lift the revenue framework on a strong first half and flagging Middle East tensions, fuel prices, and a likely summer tariff round as reasons for vigilance. The posture is "we beat, we raised where we could, and we are not going to get ahead of a back half we cannot yet see."

1. The Return to Growth

The headline milestone: the first year-over-year top-line growth since the pre-tariff Q1 FY25, with both flagship segments up double-digits and EBITDA up nearly 18%.

"Both of our reported net sales and adjusted EBITDA increased year-over-year with net sales increasing 4.9% and adjusted EBITDA growing by an impressive 17.8%. This is a significant milestone… it marks our return to growth for the first time since the first quarter of 2025." — David Maura, Chairman & CEO

Assessment: The recovery is no longer prospective; it is printing. Growth plus margin expansion plus an operationally-driven EPS beat is the trifecta the prior three quarters lacked. The organic rate (+1.5%) is the honest measure and is modest, but the direction and the segment-level double-digit growth confirm the thesis is playing out.

2. The Oaktree HPC Partnership

The strategic centerpiece: a $127M Oaktree investment ($67M preferred equity plus a $60M term loan, non-recourse to Spectrum) at an implied ~6x LTM EBITDA, with Spectrum retaining ~73% and a dedicated standalone HPC vehicle created.

"Oaktree will make a $127 million investment in the HPC business… Their investment implies a valuation for the HPC business of approximately 6x LTM EBITDA… and importantly, it is nonrecourse to Spectrum Brands Holdings… it creates optionality for HPC to become the strategic partner of choice for the industry, whether through a sale, M&A or a spin-off." — David Maura, Chairman & CEO

Assessment: A creative, value-accretive step. It brings outside capital and a respected sponsor into HPC at a defined valuation, removes the segment's funding needs from Spectrum's balance sheet (non-recourse), validates a ~6x mark, and preserves 73% of the upside plus full flexibility to sell to a higher bidder later. It is not the clean exit some shareholders wanted, but it converts an un-clocked option into a financed, separable platform, and management expects HPC EBITDA ($60M+) to grow from here, so Oaktree is entering near a trough.

3. The Raised EBITDA Guide (and Unchanged Revenue Guide)

Management raised the FY26 adjusted-EBITDA outlook to low-to-mid single-digit growth while holding net sales flat-to-LSD, an unusual combination of higher profit on unchanged revenue.

"We are reaffirming our full year earnings framework for net sales and adjusted free cash flow, but we are, however, raising our outlook for our adjusted EBITDA. We now expect adjusted EBITDA to grow low to mid-single digits compared to the prior year." — David Maura, Chairman & CEO

Assessment: Raising profit but not revenue tells you the beat is margin- and mix-driven and that management is banking the first-half outperformance into the EBITDA line rather than the top line, where it stays cautious. It is a high-quality way to raise: it does not require the back-half consumer to cooperate on volume, only for the cost and mix discipline to hold. The conservatism on revenue is prudent given the macro flags.

4. Macro Caution: The Reason the Revenue Guide Didn't Move

Despite beating both quarters of the first half, management was explicit about back-half risks: Middle East conflict, higher fuel prices pressuring discretionary income, and an expected summer round of U.S. tariff/Section 301 actions after the Supreme Court struck some measures down.

"I think Middle East turmoil, higher prices at the pump, that will generally hurt discretionary income… the U.S. administration's tariff policy, Supreme Court knocked some stuff down. They're going to redo some stuff on 301… it would be overly optimistic to not assume additional distortion or challenges that are on the horizon." — David Maura, Chairman & CEO

Assessment: This is the right framing and a credibility-builder, not a hedge. Management has been burned by tariff volatility before and is refusing to extrapolate two good quarters into a confident full-year revenue raise. It also leaves embedded upside: the framework explicitly excludes potential tariff refunds from the Supreme Court decision, a free option that could add to results.

5. Balance-Sheet Discipline and the Judicious Buyback

The company kept leverage at 1.66x, cut inventory $50M year-over-year while holding fill rates above 95%, and deliberately slowed the buyback (~100K shares, $6.8M) to preserve flexibility, with over $300M still authorized.

"We ended the second quarter with inventory actually $50 million lower than the prior year, and we still delivered fill rates well above 95%… We will, however, be judicious going forward on share repurchases to ensure flexibility as we look to capitalize on market opportunities." — David Maura, Chairman & CEO

Assessment: The working-capital execution is genuinely impressive and a direct FCF tailwind. The buyback slowdown is the notable shift: with the stock higher and M&A/Oaktree opportunities live, management is prioritizing optionality over repurchase. Reasonable, but it removes some of the structural bid that supported the stock through the recovery, which is part of why a strong print could still sell off.

6. The Pure-Play Endgame and M&A

Management reiterated the long-term vision: separate HPC, build Pet and Home & Garden into a pure-play via disciplined M&A, and be the "consolidator of choice" in both categories, all while protecting the balance sheet.

"Outside of the appliance business, we continue to seek strategic M&A opportunities within both the Pet and Home & Garden segments… we firmly believe that maintaining a healthy balance sheet provides us with a distinct competitive advantage, especially as new opportunities and deals emerge." — David Maura, Chairman & CEO

Assessment: The strategy is coherent and now has a concrete first move (Oaktree). The Pet/H&G M&A remains aspirational ("$3B Pet platform"), but the balance sheet can fund it and the buyback pause signals readiness. We continue to underwrite M&A as optionality, not base case, but the pure-play thesis is materially more credible than it was two quarters ago.

Guidance & Outlook

The shape of the raise is the story: profit up, revenue held. Implied read: management is banking the first-half beat into EBITDA, where it has visibility on cost and mix, while staying cautious on a back-half top line exposed to fuel prices, geopolitics, and the summer tariff calendar. H&G phasing: the big season is May–June and Q3/Q4, so the strong March/April start de-risks but does not yet confirm the full-year H&G plan, which assumes normal weather. Embedded options: potential tariff refunds (excluded) and any HPC value crystallization sit outside the framework. Guidance style: high-quality and conservative, raising only what is de-risked.

Analyst Q&A Highlights

What's Driving the Fastest-Growing Brands, and Can It Be Replicated

The opening question asked what characterizes the fastest-growing brands in Pet and H&G and whether the playbook can extend across the portfolio. Management pointed to the fewer-bigger-better innovation engine, consumer-insight-led storytelling, and an emerging price-pack-architecture initiative.

Q: "Could you talk a little bit about the characteristics of your fastest-growing brands in Pet and H&G? And is there an opportunity to replicate that across the rest of the brand portfolio?"
— Pete Lukas (for Bob Labick), CJS Securities

A: "You saw double-digit growth in both Pet and Home & Garden. We haven't seen that growth in a long time… the fewer, bigger, better strategy of taking real innovation and storytelling and marketing, that is actually yielding some good results… I'm really pleased with the price pack architecture we're doing in Pet, too." — David Maura, Chairman & CEO

Assessment: The answer ties the growth to a repeatable, controllable process (innovation + insights + shelf clarity) rather than a category tailwind, which supports durability. Price-pack architecture is a credible incremental lever. The replicability claim is the bull's best argument for sustained above-category growth.

Raising Profit but Not Revenue

A pointed question probed the unusual combination of a better profitability outlook with an unchanged revenue framework, asking whether specific offsets or only conservatism drove it. Management framed it as discipline against a genuinely uncertain back half.

Q: "Maybe just take a step back to this concept of revenue maintained and higher profit in this kind of a backdrop… whether you're factoring any of that into your consideration for revenue?"
— Chris Carey, Wells Fargo Securities

A: "We beat on both the revenue and EBITDA and EPS lines for Q2… if I look forward, I'm just trying to maintain vigilance, because I think Middle East turmoil, higher prices at the pump… tariff policy… I would anticipate that to be later in the summer. So I think it would be overly optimistic to not assume additional distortion." — David Maura, Chairman & CEO

Assessment: A credibility-enhancing answer. Management is choosing not to extrapolate a strong first half into a confident revenue raise, which, given its tariff scar tissue, reads as prudence rather than weakness. It also means the revenue framework carries upside if the macro cooperates, and the EBITDA raise is the part it can actually control.

How the Oaktree Partnership Came Together

A question on the years-long process behind the HPC partnership drew the fullest articulation of the strategic logic: shareholders wanted separation, prior processes were derailed by tariffs, and Oaktree chose Spectrum's platform near an EBITDA trough.

Q: "Can you give us a sense of just thought process over the years of thinking through strategic options for the business? And… how you got to this point… how you're assessing various alternatives?"
— Chris Carey, Wells Fargo Securities

A: "We've heard from our shareholders that they would prefer to see this business separate… most of our competitors in this space are either overlevered, underperforming… We believe the business is going to generate $60 million, hopefully more… Oaktree has picked a good time to come in because we expect EBITDA to actually grow from here." — David Maura, Chairman & CEO

Assessment: The "$60M+ and growing" EBITDA framing implies the ~6x mark is on trough earnings, so the implied valuation could prove conservative as HPC recovers. Pairing with a 20-year-trusted, well-regarded credit sponsor near the bottom is a smart structure. It confirms the deal as a value-creating first step toward the pure-play, not a fire sale.

The Garden Season Start and Retailer Commitment

A question on the April garden-season start and retailer inventory posture drew an upbeat but measured response: lower starting inventories, a strong April, and more replenishment ahead, with the bulk of the season still to come.

Q: "How has the garden season started in April? And industry peers said… that on-hand retailer inventories were low… just give us any color on how committed retailers are to the category."
— Madison Callinan (for Brian McNamara), Canaccord Genuity

A: "As opposed to last year, retail inventory started out much more prudent, and April is off to a great start… the bulk of the season is yet to be… retail inventory has been lower than last year, which means more replenishment orders for us." — David Maura, Chairman & CEO

Assessment: The lower-starting-inventory dynamic is a real positive: it means sell-in better tracks sell-through and sets up more replenishment if the season cooperates. Management's refusal to call the year on a strong April ("the weatherman can be wrong half the time and still keep a job") is the right discipline and consistent with holding the revenue guide.

Is the Sales Growth Sustainable, or Pull-Forward Aided

A question probed whether Q2 growth was sustainable or boosted by last-year destocking, FX, or pull-ins. Management quantified the GPC pull-forward at $9M total and insisted the core driver is fundamental share gain.

Q: "I wanted to get a little bit more of your perspective on the sales growth this quarter and the sustainability of that… Is there something that benefited Q2 that you don't expect to repeat?"
— Olivia Tong, Raymond James

A: "We did have a little bit of pull-in in pet… [$9 million in total in the Global Pet Care business]… a year ago, I was dealing with some of my biggest brands comping down 5%. This year, they're comping up that amount or more. And that is just fundamental improvement in the base business, period, end of story." — David Maura, Chairman & CEO

Assessment: Management was transparent about the $9M pull-forward, which de-risks the disclosure, and the swing from -5% to +5%-plus comps on the biggest brands is the substantive point. Net of pull-forward and FX, organic growth is modest, but the share-gain trajectory is real and is the right thing to model.

Oaktree Structure and Change-of-Control Optionality

A question asked whether the Oaktree structure preserves the ability to sell HPC outright or precludes other bidders. Management was unequivocal that full optionality remains.

Q: "Is there any structure in place to enable full change in control? Does this preclude other potential bidders from making a go at HPC if something were to come along?"
— Olivia Tong, Raymond James

A: "We own 73% of it on a fully diluted basis. So if we want to sell to somebody who wants to pay a big number, we're fully able to do that." — David Maura, Chairman & CEO

Assessment: The key structural confirmation for the option-value case. The Oaktree deal funds and separates HPC without surrendering control or foreclosing a future full sale, merger, or spin. It is the best of both: outside capital and a validated mark today, full upside and exit flexibility tomorrow.

What They're NOT Saying

1. A revenue-guide raise: Despite beating both halves of H1, management held the top-line framework, banking the beat into EBITDA only. Prudent, but it means the market gets no top-line confidence boost and the full-year still implies a softer back half.
2. A quantified HPC value or exit timeline: The Oaktree mark (~6x LTM EBITDA) is the first hard data point, but management gave no target for a full separation, no expected proceeds, and no timeline, only that optionality is preserved.
3. The organic-ex-pull-forward growth rate: Management quantified the $9M GPC pull-forward but did not spell out that organic growth net of pull-forward and the $22.9M FX is closer to flat, leaving the headline +4.9% to do the optical work.
4. FY27 commodity/oil exposure: Asked for a rule of thumb on oil-price sensitivity, management said it was "too early" and pointed only to Q4 inflation being "reasonably covered." The back-half-into-FY27 cost setup is left vague.
5. M&A specifics versus the slowed buyback: The buyback was deliberately throttled to preserve flexibility, implying a deal pipeline, but no size, target, or timing was offered for the Pet/H&G M&A the capital is being reserved for.

Market Reaction

• Pre-print setup: SPB closed at $85.03 on May 6, up 43.9% year-to-date and 37.4% over the trailing twelve months, sitting essentially at the top of its 52-week closing range ($50.35–$85.41). After three consecutive post-print rallies, the stock entered this print priced for good news.
• Reaction-day session (May 7): The stock gapped down 1.4% at the open ($83.83), fell as much as 8.6% intraday, and closed at $78.63, down 7.5% (-$6.40). Volume of 0.6M shares was 2.2x the 30-day average. The S&P 500 was roughly flat (-0.4%), so the decline was idiosyncratic.

This was a sell-the-news, not a fundamental disappointment. After a 44% YTD run to the 52-week high, a beat-and-raise with a new strategic deal was the bar, and the stock had already discounted it. The bears found enough to take profits on: organic growth of only +1.5% net of FX, ~$9M of pull-forward, an unchanged revenue guide, and a slowed buyback removing some structural support. None of that changes the trajectory, and a 7.5% pullback on the best print of the recovery arguably improves the entry for an investor who believes the second-half H&G season and continued GPC momentum will deliver. The reaction says the easy re-rate is behind the stock, not that the thesis broke.

Street Perspective

Debate: Beat-and-Raise vs. a 44% Run — What's Priced In?

Bull view: A company that returned to growth, expanded margins, raised its EBITDA guide, and just monetized part of HPC at 6x deserves to hold its gains; at ~7.6x EV/EBITDA it still trades at a deep discount to staples peers at 12–18x.

Bear view: The stock ran 44% into the print and sold off 7.5% on a beat, the clearest sign the recovery is priced; organic growth is only +1.5% net of FX and pull-forward, and the revenue guide wasn't raised.

Our take: The bull's relative-valuation argument is the decisive one: a consumer-products business returning to growth with expanding margins and an option-rich balance sheet should not trade at half the peer multiple. The sell-off reflects positioning after a big run, not a broken thesis, and the resulting entry is more attractive than the pre-print level. We side with the bull while respecting that further gains now require delivery, not re-rating.

Debate: Does the Oaktree Deal Create or Cap Value?

Bull view: It brings outside capital and a respected sponsor into HPC at a defined 6x mark near an EBITDA trough, removes funding needs from Spectrum (non-recourse), preserves 73% upside and full exit flexibility, and is a concrete step toward the pure-play.

Bear view: It is a partial solution that leaves Spectrum still consolidating a low-margin appliance business; a 6x mark may anchor expectations low, and a clean full exit keeps slipping.

Our take: This is value-creating. The 6x is explicitly on trough EBITDA that management expects to grow, so the implied mark is conservative, and the structure converts an un-clocked option into a financed, separable platform without surrendering control. We treat it as the most tangible progress on the pure-play thesis in years, with the full separation as remaining upside.

Debate: Is GPC's Growth Durable Through the Back Half?

Bull view: Two consecutive accelerating quarters of organic growth with margin now expanding, driven by share gains across four flagship brands in flat-to-down categories, supported by a stepped-up H2 marketing slate and price-pack-architecture clarity.

Bear view: Q2 was aided by ~$9M of pull-forward and FX, the category itself is still flat-to-down, and aquatics remains structurally challenged; one more quarter is needed before calling it durable.

Our take: The share-gain quality and the back-to-back acceleration tilt us bullish, and margin expansion (not just revenue) is the confirming signal. The pull-forward is a one-quarter optic, not a trend-breaker. We want the H2 prints to hold the share-gain trajectory through tougher comps, but GPC has earned the benefit of the doubt.

Model Update Needed

Valuation framing: At the $78.63 reaction-day close, SPB trades at roughly 12–13x FY26 FCF (~50% conversion of ~$300M EBITDA) and around 7.6x EV/EBITDA, with net debt of $474.6M (1.66x). That EV/EBITDA is roughly half the 12–18x multiples of branded-consumer peers, a discount we view as unwarranted for a business now growing, expanding margins, and carrying real optionality. A 12-month fair-value range of roughly $88–100 is supportable on a partial peer-multiple convergence plus the EBITDA raise, with additional, un-modeled upside from a tariff refund or HPC value crystallization. The Outperform rests on that relative-value gap closing as execution continues, not on the absolute multiple being cheap in isolation.

Thesis Scorecard Post-Earnings

Overall: Thesis confirmed across the board. Return to growth, margin expansion, an operationally-driven EPS beat, a raised EBITDA guide, and the Oaktree HPC monetization mean every pillar advanced and the lone resolved bear (visibility) stayed resolved. The single live tension is valuation: the deep-value entry is gone and the stock now sells the news, so the case has shifted to a relative-value-plus-optionality story.

Action: Maintain Outperform. The fundamentals delivered on every axis we set, the guide moved up, and the pullback to $78.63 offers a better entry than the pre-print high. We would revert to Hold if GPC growth stalls or the H&G season disappoints, and would turn more constructive still on a tariff refund, a full HPC monetization, or accretive Pet M&A. The 12-month bet is that the peer-multiple discount narrows as the recovery keeps printing.